Industry Growth Insights published a new data on “Narcolepsy Therapeutics Market”. The research report is titled “Narcolepsy Therapeutics Market research by Types (Central nervous system stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor (SSRI), Tricyclic Antidepressants, Others), By Applications (Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Secondary Narcolepsy), By Players/Companies Addrenex Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals PLC, Graymark Healthcare, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Takeda, Ligand Pharmaceuticals, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Narcolepsy Therapeutics Market Research Report
By Type
Central nervous system stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor (SSRI), Tricyclic Antidepressants, Others
By Application
Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Secondary Narcolepsy
By Companies
Addrenex Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals PLC, Graymark Healthcare, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Takeda, Ligand Pharmaceuticals, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Narcolepsy Therapeutics Market Report Segments:
The global Narcolepsy Therapeutics market is segmented on the basis of:
Types
Central nervous system stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor (SSRI), Tricyclic Antidepressants, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Secondary Narcolepsy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Addrenex Pharmaceuticals, Inc.
- Teva Pharmaceutical Industries Ltd.
- Jazz Pharmaceuticals PLC
- Graymark Healthcare, Inc.
- Arena Pharmaceuticals, Inc.
- BIOPROJET
- Takeda
- Ligand Pharmaceuticals, Inc.
Highlights of The Narcolepsy Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Central nervous system stimulants
- Sodium Oxybate
- Selective Serotonin Reuptake Inhibitor (SSRI)
- Tricyclic Antidepressants
- Others
- By Application:
- Narcolepsy With Cataplexy
- Narcolepsy Without Cataplexy
- Secondary Narcolepsy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Narcolepsy Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Narcolepsy therapeutics are medications used to treat narcolepsy. These medications help to improve the quality of sleep and reduce the number of episodes of narcolepsy.
Some of the key players operating in the narcolepsy therapeutics market are Addrenex Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals PLC, Graymark Healthcare, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Takeda, Ligand Pharmaceuticals, Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Narcolepsy Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Narcolepsy Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Narcolepsy Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Narcolepsy Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Narcolepsy Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Narcolepsy Therapeutics Market Size and Y-o-Y Growth
4.5.2 Narcolepsy Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Central nervous system stimulants
5.2.2 Sodium Oxybate
5.2.3 Selective Serotonin Reuptake Inhibitor (SSRI)
5.2.4 Tricyclic Antidepressants
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Narcolepsy With Cataplexy
6.2.2 Narcolepsy Without Cataplexy
6.2.3 Secondary Narcolepsy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Narcolepsy Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Narcolepsy Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Central nervous system stimulants
9.6.2 Sodium Oxybate
9.6.3 Selective Serotonin Reuptake Inhibitor (SSRI)
9.6.4 Tricyclic Antidepressants
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Narcolepsy With Cataplexy
9.10.2 Narcolepsy Without Cataplexy
9.10.3 Secondary Narcolepsy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Central nervous system stimulants
10.6.2 Sodium Oxybate
10.6.3 Selective Serotonin Reuptake Inhibitor (SSRI)
10.6.4 Tricyclic Antidepressants
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Narcolepsy With Cataplexy
10.10.2 Narcolepsy Without Cataplexy
10.10.3 Secondary Narcolepsy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Central nervous system stimulants
11.6.2 Sodium Oxybate
11.6.3 Selective Serotonin Reuptake Inhibitor (SSRI)
11.6.4 Tricyclic Antidepressants
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Narcolepsy With Cataplexy
11.10.2 Narcolepsy Without Cataplexy
11.10.3 Secondary Narcolepsy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Central nervous system stimulants
12.6.2 Sodium Oxybate
12.6.3 Selective Serotonin Reuptake Inhibitor (SSRI)
12.6.4 Tricyclic Antidepressants
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Narcolepsy With Cataplexy
12.10.2 Narcolepsy Without Cataplexy
12.10.3 Secondary Narcolepsy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Central nervous system stimulants
13.6.2 Sodium Oxybate
13.6.3 Selective Serotonin Reuptake Inhibitor (SSRI)
13.6.4 Tricyclic Antidepressants
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Narcolepsy With Cataplexy
13.10.2 Narcolepsy Without Cataplexy
13.10.3 Secondary Narcolepsy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Narcolepsy Therapeutics Market: Competitive Dashboard
14.2 Global Narcolepsy Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Addrenex Pharmaceuticals, Inc.
14.3.2 Teva Pharmaceutical Industries Ltd.
14.3.3 Jazz Pharmaceuticals PLC
14.3.4 Graymark Healthcare, Inc.
14.3.5 Arena Pharmaceuticals, Inc.
14.3.6 BIOPROJET
14.3.7 Takeda
14.3.8 Ligand Pharmaceuticals, Inc.
